Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety registry study of total glucosides of paeony in juvenile idiopathic arthritis
ChiCTR2400086701Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Jul 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of total glucosides of paeony in juvenile idiopathic arthritis (JIA), sponsored by Beijing Children's Hospital. Primary endpoint: Incidence of adverse events/reactions during the 8-week medication period. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
total glucosides of paeony
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on ChiCTR2400086701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086701.